References
- Mattson W, Von Eyben F, Turesson I, Wahlby S. Pred-nimustine (NSC-134087) treatment of lymphocytic and lymphocytic-histiocytic lymphomas. Cancer 1978; 41: 112–6
- Kaplan R S, Wiernek P H. Neurotoxicity of antitumor agents. Toxicity of chemotherapy, M C Perry, J W Yarbro. Grune and Stratton Inc., Orlando 1984; 365–431
- Karch F E, Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther 1977; 21: 247–54
- Williams S A, Makker S P, Grupe W E. Seizures—A significant side-effect of chlorambucil therapy in children. J Pediatr 1978; 93: 516–8
- La Delta I, Bayer N, Myers R, Hoffstein V. Chlorambucil-induced myoclonic seizures in an adult (letter). J Clin Oncol 1985; 3: 1691–2
- Gaver R C, Deeb G, Pittman K A, Isdell B F, Mittelman A, Smyth R D. Disposition of orally administered 14C-pred-nimustine in cancer patients. Cancer Chemother Pharmacol 1983; 11: 139–42